Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Security class unavailable · CUSIP: 25253X207

Event date: 2018-12-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
657,895
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-19-001703
Form type
SC 13G
Filer
CHANG NANCY T
CIK
CIK 1135041
Filed
Feb 01, 2019
Reporting period
Dec 06, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub